Home
About
Publications Trends
Recent Publications
Expert Search
Archive
epigallocatechin gallate
What Are the Sources of EGCG?
The primary source of EGCG is green tea. Other sources include white tea and, to a lesser extent, black tea. EGCG supplements are also available, but it is important to consult a healthcare professional before starting any new supplement regimen.
Frequently asked queries:
What Types of Cancer Could EGCG Potentially Affect?
What Are the Sources of EGCG?
Are There Any Clinical Trials Involving EGCG?
What is the Prognosis for Cancer Patients with Malabsorption?
Who Can Benefit from Targeted Agents?
What Challenges Exist in Mutation Detection?
How are Treatments Customized?
How Do Vulnerability Scanners Work?
What Role Do Hydration and Physical Activity Play?
What is the Future of Proteomic Markers in Cancer Research?
How do genetic factors intersect with demographic factors in cancer?
What is the Future of Cell Markers in Cancer Research?
Are There Specific Types of Lubricants and Moisturizers Recommended for Cancer Patients?
What Mechanisms Link These Meats to Cancer?
What are the key components of cancer prevention?
What are Immunosuppressive Treatments?
How Do Normal Signaling Pathways Work?
How Can Cost Effectiveness be Improved?
Why is a Pathology Report Important in Cancer Diagnosis?
How are Cell Cultures Established?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe